Medicare Enrolled

Dr. Richard Lane, M.D.

Ophthalmology · San Antonio, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Mixed engagement
9480 HUEBNER RD STE 310, San Antonio, TX 78240
2106151311
In practice since 2006 (20 years)
NPI: 1922086347 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lane from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lane? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lane

Dr. Richard Lane is an ophthalmology in San Antonio, TX, with 20 years in practice. Based on federal Medicare data, Dr. Lane performed 41,700 Medicare services across 4,208 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lane received a total of $16,675 from 28 pharmaceutical and/or device companies across 94 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lane is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 1% volume in TX$ $16,675 industry payments

Medicare Practice Summary

Medicare Utilization ↗
41,700
Medicare services
Top 1% in TX for ophthalmology
4,208
Unique beneficiaries
$115
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,085 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Eye injection (Vabysmo/faricimab)26,705$29$114
Aflibercept eye injection (Eylea)3,870$690$2,699
Retinal imaging (OCT scan)3,057$29$127
Eye injection for retinal disease2,440$92$445
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg1,511$217$840
Injection, pegcetacoplan, intravitreal, 1 mg901$120$458
Comprehensive eye exam, established patient800$88$395
Injection, dexamethasone, intravitreal implant, 0.1 mg399$153$555
Injection, ranibizumab, 0.1 mg395$183$775
Office visit, established patient (20-29 min)357$62$283
Eye exam, established patient, focused348$60$280
Comprehensive eye exam, new patient234$103$466
Exam of retinal blood vessels using a special camera after injection of a dye179$104$394
Retinal photography (fundus photo)113$27$116
Unclassified drugs73$1,890$7,509
New patient office visit (45-59 min)66$118$518
Unclassified biologics66$1,859$7,074
Office visit, established patient (30-39 min)58$96$400
Compounded drug, not otherwise classified37$73$349
Removal of eye fluid (vitreous) between lens and retina19$664$2,761
Removal of membrane of retina19$838$3,560
Removal of implant material from inside of eye19$676$2,781
2d ultrasound scan of eye tissue and structures18$38$151
Insertion of prosthetic lens16$323$2,372
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$16,675
Total received (2018-2024)
Avg $2,382/year across 7 years
Top 9% in TX for ophthalmology
28
Companies
94
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Other
Charitable contributions, space rental, and other categories
$8,510 (51.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,040 (30.2%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$3,125 (18.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,465
2023
$524
2022
$9,468
2021
$1,911
2020
$626
2019
$1,358
2018
$323

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
US Retina LLC
$11,635
EyePoint Pharmaceuticals US, Inc.
$2,200
Genentech USA, Inc.
$664
Alcon Vision LLC
$278
Harrow Eye, LLC
$206
ABBVIE INC.
$204
Regeneron Healthcare Solutions, Inc.
$184
OPTOVUE, INC.
$120
Janssen Global Services, LLC
$114
Allergan, Inc.
$109
Allergan Inc.
$106
Sun Pharmaceutical Industries Inc.
$104
Bausch & Lomb Americas Inc.
$93
Genentech, Inc.
$86
Alimera Sciences, Inc.
$83
TissueTech, Inc.
$81
Apellis Pharmaceuticals, Inc.
$74
Biogen, Inc.
$71
Astellas Pharma US Inc
$61
Alexion Pharmaceuticals, Inc.
$43
Mallinckrodt Hospital Products Inc.
$38
Ocular Therapeutix, Inc.
$28
Carl Zeiss Meditec AG
$19
Halozyme Inc
$16
VYERA PHARMACEUTICALS, LLC
$15
Spark Therapeutics, Inc.
$15
Novartis Pharmaceuticals Corporation
$14
Shire North American Group Inc
$13
Top 3 companies account for 87.0% of total payments
Associated products mentioned in payments ›
ACTHAR · BEOVU · BROMSITE · BYOOVIZ · Constellation · DEXTENZA · DEXYCU · Daraprim · EYLEA · EYLEA HD · EYP-1901 · HYLENEX RECOMBINANT · IHEEZO · ILUVIEN · LUXTURNA · Lucentis · None Specified · OZURDEX · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prokera · SUSVIMO · Susvimo · Syfovre · Vabysmo · XIIDRA · XIPERE · XR · YUTIQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Payments are distributed across multiple categories with no single dominant type. Total industry engagement is in the top 9% for ophthalmology in TX.

Equivalent to $40 per 100 Medicare services performed
Looking for a ophthalmology in San Antonio?
Compare ophthalmologys in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologys nearby

Geographic Context

Ophthalmologys within 10 mi
164
Per 100K population
8.0
County median income
$70,571
Nearest hospital
SAN ANTONIO BEHAVIORAL HEALTHCARE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Lane is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and high industry engagement (mixed engagement, top 9%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Lane experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Lane performed 26,705 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lane receive payments from pharmaceutical companies?
Yes. Dr. Lane received a total of $16,675 from 28 companies across 94 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lane's costs compare to other ophthalmologys in San Antonio?
Dr. Lane's average Medicare payment per service is $115. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lane) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →